Stoky
Back to explore
N
NoahListening
A
AshListening
0:00 / 0:00I. Business Overview and Strategic Initiatives
RVTY logo

Revvity Navigates $25 Million Tariff Headwind While Growing Revenue to $2.86 Billion

RVTY10-KFiling Date: 2/24/2026
Revvity, Inc.
Description

What this story covers

Revvity's 2025 10-K reveals 4% revenue growth to $2.86 billion, driven by Life Sciences software and Diagnostics. Despite $25 million in tariff costs and China headwinds, the company maintained strong liquidity and aggressive shareholder buybacks.

Story snapshot

CompanyRevvity, Inc.
TickerRVTY
VariantStandard detailed
Duration12:02
Filing type10-K
PeriodAnnual 2025
IndustryHealthcare & Pharmaceuticals
Accession0000031791-26-000012
Sources1

Full Story Script

Content not available for this story.

Primary Sources

sec_filing10-KView on SEC.gov →

Ask Noah

Question the story, source filings, and key financial signals.

Sign in to chat with Noah

Ask questions about revenue, margins, risk factors, filings and more. Noah uses retrieval-augmented analysis over raw financial disclosures.

Sign in